Mais Notícias
Clinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant Recipients
In phase-3 trial, inactivated SARS-CoV-2 vaccine (CoronaVac, Sinovac Life-Sciences, Beijing, China) was associated with 71.1% seroconversion at least 14-days after the 2nddose, showing 50.7% efficacy against symptomatic COVID-19 among healthcare…
Blogs
Saúde e Bem Estar
Cursos e Eventos
Perda de visão pode ser tumor na hipófise, alerta especialista
Abril
30
2014
Saúde e Bem Estar
O Hospital de Transplantes do Estado de São Paulo, unidade da Secretaria de Estado da Saúde de ...
